Hypermarcas (OTCMKTS:HYPMY) Stock Price Up 10% - Here's What Happened

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) shares shot up 10% during mid-day trading on Wednesday . The company traded as high as $4.95 and last traded at $4.95. 102 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 17,428 shares. The stock had previously closed at $4.50.

Hypermarcas Stock Performance

The company has a current ratio of 1.26, a quick ratio of 0.80 and a debt-to-equity ratio of 0.63. The stock has a fifty day moving average price of $4.30 and a 200-day moving average price of $3.60. The firm has a market capitalization of $2.91 billion, a price-to-earnings ratio of 19.17 and a beta of 0.79.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported ($0.04) earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 6.95% and a net margin of 12.51%. The company had revenue of $184.34 million during the quarter.

Hypermarcas Announces Dividend

The firm also recently declared a dividend, which will be paid on Friday, January 8th. Investors of record on Tuesday, July 1st will be issued a dividend of $0.0345 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a yield of 2.81%. Hypermarcas's dividend payout ratio is 45.83%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.